Home EEG monitoring for epilepsy patients
DigitalEPI - A Prospective Pilot Study
This study tests a new home EEG system for people with epilepsy to see if it works as well as the traditional method used in hospitals and if it can help improve their care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 18 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Karl Landsteiner Institute for Clinical Epilepsy Research and Cognitive Neurology Government |
| Locations | 1 site (Vienna) |
| Trial ID | NCT05739669 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of a novel dry electrode EEG system for home monitoring of epilepsy patients compared to traditional wet electrode systems used in clinical settings. It aims to determine the quality of EEG recordings made by patients at home and how they compare to those conducted by specialized staff in a clinical environment. The study also explores the potential for automatic EEG analysis using AI algorithms to enhance diagnostic capabilities. By enabling home monitoring, the study seeks to improve access to advanced epilepsy care for patients who cannot be admitted to hospitals.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older with a diagnosis of epilepsy who have experienced at least one seizure in the past year.
Not a fit: Patients with psychogenic non-epileptic seizures (PNES) or those unable to comply with trial procedures may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve access to epilepsy diagnostics and monitoring for patients unable to attend specialized centers.
How similar studies have performed: While the use of home EEG monitoring is a growing field, this specific approach using dry electrodes and AI analysis is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed epilepsy * ≥ 1 seizure during the last year * ≥ 1 routine EEG at the investigation center or VEM * Age ≥ 18 years Exclusion Criteria: * History of PNES * Inability to comply with the trial procedures * Inability to give informed consent * Pregnant and breastfeeding patients
Where this trial is running
Vienna
- Department of Neurology, Clinic Hietzing — Vienna, Austria (Recruiting)
Study contacts
- Principal investigator: Christoph Baumgartner, MD — Department of Neurology, KLI Clinical Epilepsy Research - Clinic Hietzing, Vienna, Austria
- Study coordinator: Johannes Koren, MD, PhD
- Email: johannes.koren@gesundheitsverbund.at
- Phone: 00431801102524
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.